FIELD: organic chemistry, biochemistry, virology. SUBSTANCE: invention relates to novel substituted pyrimidinethioalkyl or alkylester compounds, their pharmaceutically acceptable salts, hydrates, N-oxides and method of inhibition of viral reverse transcriptase activity. Proposed compounds can be used in treatment of HIV-infected patients. Proposed compounds correspond to the general structural formula (I) 
where m = 0 or 1; R1 is taken among the group consisting of: -C=CH, -CO2R53, -CONR54R55 or residues of compounds of the formulas (A) 
, (B) 
and (C) 
where radical values are given in the invention claim. Method of inhibition of activity of viral reverse transcriptase involves administration to patients of effective dose of compound of the formula (I). EFFECT: new compounds indicated above, improved method of inhibition. 20 cl, 13 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHENYLOXAZOLIDINONES HAVING C-C-BOND WITH 4-8-MEMBERED HETEROCYCLIC RINGS | 1996 |
|
RU2175324C2 |
| RING-SUBSTITUTED PHENYLOXAZOLIDINONES WITH HETEROAROMATIC RINGS AS ANTIBACTERIAL AGENTS | 1996 |
|
RU2154645C2 |
| BICYCLIC OXAZINE- OR THIAZINE-OXAZOLIDINONES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHODS OF TREATMENT OF PATIENTS WITH MICROBIAL INFECTIONS | 1995 |
|
RU2128660C1 |
| ALKYL-SUBSTITUTED CYCLIC AMINES AS SELECTIVE LIGANDS OF D3-DOPAMINE | 1997 |
|
RU2185372C2 |
| NEW DERIVATIVES OF HYDROXAMIC ACID USEFUL FOR TREATMENT OF PATIENTS WITH DISEASES ASSOCIATED WITH DEGENERATION OF CONNECTIVE TISSUE | 1997 |
|
RU2168497C2 |
| NEW INTERMEDIATE PRODUCTS AND METHOD OF PREPARING CAMPTOTECINE (CPT-11) AND RELATED COMPOUNDS | 1996 |
|
RU2164917C2 |
| 14-SUBSTITUTED MARCFORTINES | 1994 |
|
RU2131877C1 |
| ANTIMICROBIAL PHENYLOXAZOLIDINONES | 1995 |
|
RU2134692C1 |
| OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 1998 |
|
RU2215740C2 |
| AZAANTRACYCLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2159245C2 |
